Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K230890
    Device Name
    ISE Electrodes
    Date Cleared
    2023-09-08

    (161 days)

    Product Code
    Regulation Number
    862.1600
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ISE Electrodes on the RX Imola can be used for measurement of the electrolytes sodium, potassium and chloride in serum and urine and for use in diagnosis and treatment of electrolyte imbalance. For in vitro diagnostic use only.

    Device Description

    RX imola is an automated clinical chemistry analyzer complete with dedicated analyzer software. Software functions of the analyzer include the facility to interact with a host computer for direct download of test method selection details for individual samples. A barcode system is used for the rapid identification of patient samples, reagents and QC samples, In addition, the RX imola is fitted with an Ion Selective Electrode (ISE) module that operates in conjunction with specific electrodes for the quantitative in vitro diagnostic determination of Sodium, Potassium and Chloride in serum and urine.

    AI/ML Overview

    The provided document is a 510(k) summary for a medical device (ISE Electrodes) and outlines the performance characteristics to demonstrate substantial equivalence to a predicate device. It focuses on the analytical performance of the device rather than a clinical study involving human patients or complex AI algorithms. Therefore, many of the requested points related to multi-reader multi-case studies, expert ground truth establishment for AI, and training/test set sample sizes for AI are not applicable to this type of submission.

    The document details the acceptance criteria and the study that proves the device meets those criteria for analytical performance.


    1. Table of Acceptance Criteria and Reported Device Performance

    For this type of device (Ion Selective Electrodes for measuring common electrolytes), the "acceptance criteria" are typically defined by demonstrating that the new modified device performs equivalently to the existing cleared predicate device and meets established analytical performance guidelines (e.g., CLSI standards for precision, linearity, and interference). The document implicitly defines acceptance by stating "The acceptance criteria ... was met" or "The results... support the claimed measuring ranges."

    Here's a summary of the performance demonstrated based on the provided text:

    Performance MetricAnalyte & Specimen TypeAcceptance Criteria (Implicit - based on meeting CLSI/predicate equivalence)Reported Device Performance
    Precision/ReproducibilitySodium, Potassium, Chloride (Serum & Urine)Met CLSI EP05-A3 guidelines for 'Evaluation of Precision of Quantitative Measurement Procedures'; demonstrated acceptable CVs/SDs comparable to predicate.Sodium (Serum): CV% (Total Precision) ranged from 1.1% to 2.2%
    Potassium (Serum): CV% (Total Precision) ranged from 0.9% to 4.1%
    Chloride (Serum): CV% (Total Precision) ranged from 0.9% to 2.2%
    Sodium (Urine): CV% (Total Precision) ranged from 2.4% to 5.9%
    Potassium (Urine): CV% (Total Precision) ranged from 2.2% to 4.0%
    Chloride (Urine): CV% (Total Precision) ranged from 2.3% to 3.6%
    Linearity/Reportable RangeSodium (Serum): 90-200 mmol/LMet CLSI EP6-A guidelines for 'Evaluation of the Linearity of Quantitative Measurement Procedures'; deviation from linearity less than 5%.Sodium (Serum): 90 to 200 mmol/L supported.
    Sodium (Urine): 45-318 mmol/LSodium (Urine): 45 to 318 mmol/L supported.
    Potassium (Serum): 0.5-11 mmol/LPotassium (Serum): 0.5 to 11 mmol/L supported.
    Potassium (Urine): 7-168 mmol/LPotassium (Urine): 7 to 168 mmol/L supported.
    Chloride (Serum): 72-210 mmol/LChloride (Serum): 72 to 210 mmol/L supported.
    Chloride (Urine): 61-319 mmol/LChloride (Urine): 61 to 319 mmol/L supported.
    Specificity/InterferenceSodium, Potassium, Chloride (Serum & Urine)Met EP07 3rd Edition 'Interference Testing in Clinical Chemistry'; demonstrated no significant interference up to specified levels for various substances (e.g., Hemoglobin, Bilirubin, Triglycerides).No significant interference observed for detailed endogenous and exogenous substances at specified levels in serum and urine.
    Method Comparison (Correlation with Predicate)Sodium (Serum)Linear regression equation and correlation coefficient (R) demonstrating strong correlation to predicate device.Y = 1.06x - 8.4 kg/mol, R = 0.973
    Potassium (Serum)Y = 1.02x - 0.09, R = 0.998
    Chloride (Serum)Y = 1.03x - 6.59, R = 0.987
    Sodium (Urine)Y = 0.92x + 6.43, R = 0.997
    Potassium (Urine)Y = 1.03x = 1.02, R = 0.999
    Chloride (Urine)Y = 0.89x + 18.49, R = 0.986

    2. Sample Size Used for the Test Set and Data Provenance

    The "test set" in this context refers to the samples used for analytical validation studies.

    • Precision Studies:
      • Serum: Two levels of control material and at least five human serum samples for each analyte (Sodium, Potassium, Chloride). Tested twice per day for 20 non-consecutive days, two replicates per run. This totals 80 data points per measured sample/control (20 days * 2 runs/day * 2 replicates/run).
      • Urine: Two levels of urine controls and at least five urine patient pools for each analyte. Tested twice per day for 20 non-consecutive days, two replicates per run. This totals 80 data points per measured sample/control.
    • Linearity Studies: 9 levels of samples used for each analyte and specimen type.
    • Method Comparison (Correlation):
      • Serum: 105 patient serum samples for Sodium, 109 for Potassium, 104 for Chloride.
      • Urine: 72 patient urine samples for Sodium, 84 for Potassium, 90 for Chloride.
    • Data Provenance: The document does not explicitly state the country of origin for the patient samples. The studies were conducted in-house by Randox Laboratories Limited, which is based in the United Kingdom. The studies were retrospective in the sense that they used collected samples to validate the device's performance, not in the sense of analyzing pre-existing patient data outside a controlled study.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

    • N/A. This is an in vitro diagnostic (IVD) device for measuring electrolyte concentrations using Ion Selective Electrodes. The "ground truth" for analytical performance studies is established by quantitative measurements using reference methods or by the known concentrations of controls/calibrators, not by human expert interpretation like radiologists.

    4. Adjudication Method for the Test Set

    • N/A. As this is an analytical performance study for an IVD device, there is no human adjudication method required. Performance is based on quantitative measurements.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • N/A. This is not an AI-based device, nor is it a device that involves human "readers" interpreting images or clinical data. Therefore, an MRMC study is not relevant.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

    • Partially Applicable / Context Dependent. The device (ISE Electrodes on the RX Imola) performs measurements automatically. The performance data presented (precision, linearity, interference, method comparison) is the "standalone" performance of the device as it directly measures the analytes, without requiring human "interpretation" of the analytical result itself beyond standard lab procedures. There is no separate algorithm being tested in the AI sense.

    7. The Type of Ground Truth Used

    • Reference Method / Known Concentration:
      • For precision and linearity studies, ground truth is established by using control materials and prepared linearity samples with known, validated concentrations or statistically derived consensus values from repeated measurements.
      • For method comparison, the "ground truth" is effectively the measurements obtained from the predicate device (the RX imola with the previous ISE unit, K052914), against which the new device (RX imola with new ISE electrodes, K230890) is correlated to demonstrate equivalence.
      • For interference studies, known interfering substances are added at specific concentrations to samples to evaluate their effect on the measurement.

    8. The Sample Size for the Training Set

    • N/A (in the AI/machine learning sense). This device does not involve a "training set" in the context of machine learning. It's a chemical measurement system with established electrochemical principles. Standard calibration and quality control procedures are part of its normal operation, but these are not "training sets" in the AI development sense.

    9. How the Ground Truth for the Training Set Was Established

    • N/A (in the AI/machine learning sense). As there is no AI training set, this question is not applicable. The device's operational "knowledge" comes from its manufacturing specifications, calibration protocols using reference materials, and the underlying physical and chemical principles of ion-selective electrodes.
    Ask a Question

    Ask a specific question about this device

    K Number
    K182042
    Date Cleared
    2018-10-23

    (85 days)

    Product Code
    Regulation Number
    862.1145
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Randox Calcium (Ca) device is intended for the quantitative in vitro determination in serum, plasma and urine. This product is suitable for use on the RX series analyzer, RX daytona plus. Such measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases and chronic renal failure.

    Device Description

    The Randox Calcium (Ca) kit consists of a ready to use reagent solution.

    AI/ML Overview

    The Randox Calcium (Ca) device is an in vitro diagnostic intended for the quantitative determination of calcium concentration in serum, plasma, and urine on the RX series analyzer RX daytona plus. The device demonstrates substantial equivalence to the predicate device, the ADVIA Chemistry Calcium_2 (CA_2) Method (K083386), based on performance characteristics including precision, linearity, analytical specificity, and method comparison.

    1. Table of Acceptance Criteria and Reported Device Performance

    Performance CharacteristicAcceptance Criteria (Implicit from validation studies)Reported Device Performance (Randox Calcium (Ca))
    Precision (Serum)Total CV% for Serum:Lot 1: Level 1: 4.1%, Level 2: 3.6%, Level 3: 3.7%, Level 4: 3.7%
    - Level 1: ≤ 4.2% (based on predicate value)Lot 2: Level 1: 4.2%, Level 2: 4.2%, Level 3: 4.1%, Level 4: 4.0%
    - Level 2: ≤ 4.2% (based on predicate value)
    - Level 3: ≤ 4.1% (based on predicate value)
    - Level 4: ≤ 4.0% (based on predicate value)
    Precision (Urine)Total CV% for Urine:Lot 1: Level 1: 4.6%, Level 2: 4.0%, Level 3: 4.0%, Level 4: 3.9%
    - Level 1: ≤ 4.0% (based on predicate value)Lot 2: Level 1: 4.0%, Level 2: 4.1%, Level 3: 4.0%, Level 4: 3.7%
    - Level 2: ≤ 4.1% (based on predicate value)
    - Level 3: ≤ 4.0% (based on predicate value)
    - Level 4: ≤ 3.7% (based on predicate value)
    Linearity (Serum)Correlation Coefficient r ≥ 0.99Lot 1: r = 1.00; Lot 2: r = 1.00
    Reportable Range: 1.0 - 16 mg/dLLot 1: 1.0 - 16 mg/dL; Lot 2: 1.0 - 16 mg/dL
    Linearity (Urine)Correlation Coefficient r ≥ 0.99Lot 1: r = 1.00; Lot 2: r = 1.00
    Reportable Range: 1.0 - 32 mg/dLLot 1: 1.0 - 32 mg/dL; Lot 2: 1.0 - 32 mg/dL
    Analytical SpecificityDeviation from control < ±10%All tested interferents (Haemoglobin, Bilirubin, Triglycerides, Intralipid, Ascorbic Acid, Ethanol, Boric Acid, Gamma Globulin, Glucose, Human Serum Albumin, Sodium Oxalate, Sodium Fluoride, Sodium Chloride) did not interfere at indicated concentrations.
    Method Comparison (Serum)Correlation Coefficient r ≥ 0.99r = 0.99
    Linear Regression: y ≈ x (slope ≈ 1, intercept ≈ 0)y = 0.99x - 0.10
    Method Comparison (Urine)Correlation Coefficient r ≥ 0.99r = 0.99
    Linear Regression: y ≈ x (slope ≈ 1, intercept ≈ 0)y = 0.98x - 0.24
    Matrix Comparison (Serum vs Plasma)Correlation Coefficient r ≥ 0.99r = 0.99
    Linear Regression: y ≈ x (slope ≈ 1, intercept ≈ 0)y = 0.97x + 0.22

    Note: Acceptance criteria are often implied by context (e.g., successful demonstration of performance consistent with CLSI guidelines, or by direct comparison with predicate device performance which sets an implicit standard). For precision, specific numerical thresholds are listed based on the demonstrated performance of the predicate device or generally accepted clinical chemistry standards. For linearity and method comparison, r ≥ 0.99 and a linear regression close to y=x are standard and implied criteria for equivalence. For analytical specificity, a deviation of < ±10% is explicitly stated as the sponsor's acceptance criterion.

    2. Sample sizes used for the test set and the data provenance:

    • Precision (Serum): Not explicitly stated, but "two levels of controls, calibration material and human serum samples for Calcium" were tested across two lots. Each run included two replicates per sample, tested twice per day for 20 non-consecutive days. This implies a significant number of measurements for each level/lot (e.g., 2 samples * 2 replicates * 2 times/day * 20 days = 160 data points per lot/level).
    • Precision (Urine): Similar to serum precision, "two levels of urine controls, calibration material and human urine samples for Calcium" were tested across two lots, with two replicates per run, twice per day for 20 non-consecutive days.
    • Linearity (Serum): 11 levels of samples were prepared.
    • Linearity (Urine): 11 levels of samples were prepared.
    • Analytical Specificity (Serum): Not explicitly stated, but interferent levels were tested at Calcium concentrations of 8 mg/dL and 12 mg/dL.
    • Analytical Specificity (Urine): Not explicitly stated, but interferent levels were tested at Calcium concentrations of 9 mg/dL and 22.8 mg/dL.
    • Method Comparison (Serum): 111 serum patient samples.
    • Method Comparison (Urine): 100 urine patient samples.
    • Matrix Comparison (Serum vs Plasma): 47 matched patient sample pairs.

    Data Provenance: The document does not specify the country of origin for the patient samples. The studies are described as analytical performance studies, meaning they are likely retrospective in the sense that samples were collected and then analyzed for the study.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    This is an in vitro diagnostic (IVD) device for quantitative biochemical measurement. The "ground truth" for such devices is established by reference methods or validated comparative methods, not typically by expert interpretation of images or clinical assessments in the same way as, for example, an imaging AI device. For the method comparison studies, the predicate device (ADVIA Chemistry Calcium_2 (CA_2) Method) serves as the reference for comparison, which itself is a cleared IVD. Therefore, "experts" in the sense of clinicians or radiologists establishing ground truth are not applicable here.

    4. Adjudication method for the test set:

    Not applicable. The performance is evaluated using quantitative measurements against recognized analytical standards and comparisons with a predicate device, not through adjudication of expert interpretations.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    Not applicable. This is an in vitro diagnostic device, not an AI-powered diagnostic imaging or decision-support system that involves human readers interpreting cases.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

    Yes, the studies presented are all standalone performance evaluations of the Randox Calcium (Ca) assay and the RX daytona plus analyzer. This device provides a quantitative measurement and does not involve human-in-the-loop interpretation once the sample is processed by the instrument.

    7. The type of ground truth used:

    The ground truth or reference standard for this type of device is established through:

    • Reference materials/calibrators: used for precision and linearity studies.
    • Comparative method (Predicate Device): For method comparison, the results generated by the predicate device (ADVIA Chemistry Calcium_2 (CA_2) Method) on patient samples served as the comparative "truth" or reference.
    • Spiked samples: For analytical specificity studies, known concentrations of interferents were added to samples with known calcium concentrations.

    8. The sample size for the training set:

    Not applicable. This is a chemical assay, not a machine learning or AI algorithm that requires a "training set" in the computational sense. The "training" of the assay involves the development and optimization of the reagent formulation and instrument parameters, which is a chemical and engineering process, not a data-driven training process in the AI context.

    9. How the ground truth for the training set was established:

    Not applicable, as there is no "training set" in the context of an AI algorithm. The performance of the chemical assay is established through rigorous analytical validation studies as described above.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1